Clinically significant mood disorders are among the most common psychiatric illness in the elderly (Blazer et al. 1987; Parmalee et al. 1992; Henderson et al. 1997) . They increase psychosocial and economic morbidity and contribute to the relatively high rate of suicide in the elderly Wells et al. 1989; Unutzer et al. 1997; Penninx et al. 1999) . Depression in the elderly is consistently associated with medical illness, and this relationship has been observed in virtually all clinical settings including acute, long-term care, and ambulatory programs (Coulehan et al. 1990; Lustman et al. 1992; Caine et al. 1993; Gierz and Jeste 1993; Katz et al. 1994; Lacro and Jeste 1994; Frasure-Smith et al. 1995; Katz 1996; Borson et al. 1998) . Depression is associated with a broad spectrum of medical disorders including cardiovascular, cerebrovascular, musculoskeletal, metabolic, and pulmonary illnesses and malignancies (Coulehan et al. 1990; Lustman et al. 1992; Caine et al. 1993; Gierz and Jeste 1993; Katz et al. 1994; Lacro and Jeste 1994; Frasure-Smith et al. 1995; Katz 1996; Zubenko et al. 1997; Borson et al. 1998) . Acknowledging this robust connection between medical disorders and depression, the National Institutes of Health consensus conference on depression in late life concluded, "The hallmark of depression in the elderly is its association with medical comorbidity"(National Insti- tutes of Health 1992). Despite these observations, the precise nature of the relationship between mood and medical disorders and the pathways that lead from medical illness to clinical depression remain elusive.
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The application of magnetic resonance imaging (MRI) to the study of late-life depression has provided information on the neuroanatomical substrates of depression (Rabins et al. 1991; Coffey et al. 1993; Krishnan 1993; Sheline et al. 1996; Kumar et al. 1997a Kumar et al. , 1997b Kumar et al. , 1998 Lai et al. 2000) . Late-life depression is associated with smaller focal brain volumes together with increased MRI-determined high-intensity lesion in the brain (areas that appear bright on T2 and proton density weighted images) when compared with nondepressed controls. The decreases in brain volume appear to be relatively focal and have been described in the prefrontal lobe, hippocampus, and the caudate nucleus (Krishnan 1993; Sheline et al. 1996; Kumar et al. 1998) . The high-intensity lesions are also distributed in the neocortical and subcortical areas. The increased prevalence of high-intensity lesions in the brain together with their putative relationship to vascular disease in some samples has led to a resurgence of interest in the role of vascular mechanisms in the pathophysiology of late-life major depression (Morris and Rapoport 1990; Alexopoulos et al. 1997; Krishnan et al. 1997) . However, the mechanisms by which lesions and vascular disease influence mood disorders remain unknown, and the relative importance of high-intensity lesions in the neocortical areas versus the basal ganglia remain unclarified (Sato et al. 1999; Steffens et al. 1999) . A recent report from the Cardiovascular Health Study, a large community-based epidemiological study, also suggested that the impact of cardiovascular disease and lesions on depressive symptoms may be mediated by the subject's cognitive status and the level of functional activity (Sato et al. 1999) .
We recently demonstrated that atrophy and highintensity lesions increased the statistical odds (odds ratio) of developing major depressive disorder in the elderly (late-life MDD) (Kumar et al. 2000) . Smaller frontal lobe volumes and larger whole-brain high-intensity lesion volumes appeared to independently increase the odds of developing late-life MDD in our study (see Table  1 ). The purpose of our current study was to further examine specific pathways that may lead from cerebrovascular risk factors, nonvascular medical burden, age, and atrophy to late-life MDD and thereby construct a more holistic model of the pathophysiology of late-life depression. Based on our earlier correlations and relationships observed between clinical and neuroimaging measures, we developed an a priori model of pathways to MDD. We hypothesized that vascular and nonvascular medical comorbidity contribute to high-intensity lesions in the brain that lead to MDD. This would represent one pathway to MDD. Smaller brain volume in the frontal lobes would represent a distinct path to late-life MDD independent of medical comorbidity. To examine the role of cognitive status in the paths to MDD, we additionally hypothesized that in our MDD sample, cognitive state would be secondary to the primary mood state, and the path would lead from MDD to cognitive compromise.
MATERIALS AND METHODS

Patients and Methods
Our samples were comprised of 51 patients with MDD and 30 nondepressed controls and have been recently reported on (Kumar et al. 2000) . All patients diagnosed with depression met DSM IV criteria for MDD (American Psychiatric Association 1994) and had a score of 15 or greater on the 17-item Hamilton Depression Rating Scale (Hamilton 1967) . Patients were recruited from the inpatient and ambulatory geropsychiatry programs at the University of Pennsylvania Medical Center. After complete description of the study to the subjects, written informed consent was obtained. MDD patients had several stable comorbid medical disorders but were free of other disorders of the central nervous system. Patients and controls received thorough medical and neurologic exams and laboratory tests that included complete and differential blood counts, electrolytes, hepatic and renal screens, thyroid, and serology studies. None of the subjects had a history or mental status exam that was consistent with clinical dementia and all had mini mental state exam (MMSE) scores in the normal range (Folstein et al. 1975 ). The MMSE served as the marker of cognitive state in the current analyses.
The Cumulative Illness Rating Scale (CIRS), which is a 12-item organ system-based instrument, was used to estimate medical burden in patients and controls (Linn et al. 1968) . Organ dysfunction is rated on a 0-4 severity scale for 12 organ systems, such as cardiac, vascular, gastrointestinal, endocrine, and genitourinary. In order to independently evaluate the impact of vascular and nonvascular disorders on MDD, we developed a composite estimate of noncardiovascular medical burden by summing the 10 noncardiovascular components of the Noncardiovascular (NCRDV) of the Cumulative Illness Rating Scale (CIRS). The American Heart Association Stroke Risk Prediction Chart was used to quantify cerebrovascular risk factor (CVRF) burden in all subjects (American Heart Association 1990; Wolf et al. 1991) . This composite index comprises eight factors-age, systolic blood pressure, treatment of hypertension, diabetes, smoking, ischemic heart disease, atrial fibrillation, and left ventricular hypertrophy. In our analysis, the composite CVRF score reflects the total score minus the points attributable to age. This approach permits us to concurrently assess the role of both cerebrovascular risk factors and nonvascular medical illness in late-life MDD more precisely. The impact of age on clinical and neuroimaging measures and MDD was independently assessed. Details on our clinical methods, including inclusion and exclusion criteria, have been recently published (Kumar et al. 2000) .
MR images were obtained on a 1.5 Tesla GE Signa scanner with head coil. T2 and proton density weighted images were obtained (TR ϭ 3000, TE ϭ 30 and 60 msec). Slices were 5 mm contiguous, field of view was 22 cm, and all images were displayed on a 256 ϫ 256 matrix. Anatomical boundaries used to demarcate regional lobar boundaries and our segmentation methods have been previously described (Cowell et al. 1994 ). The fuzzy connectedness approach was used to quantify whole-brain high-intensity lesion volume in MR images. Frontal lobe and whole-brain high-intensity lesion volumes were normalized to total intracranial volume for our analysis (Udupa and Samarasekera 1996) .
Statistical Methods
The path analyses were performed using Mplus (Version 1.03; Muthen 1984; www.statmodel. com), a general modeling program. We used a structural equation approach that permitted simultaneous evaluation of the multistage causal models that were of interest. Mplus permits specification of a categorical dependent variable (depression diagnosis). Principal interest centered on the multilevel path model suggested by our previous work. We also evaluated several alternative models in which additional paths were added to determine if any significant improvement on the primary model was possible. The path coefficients between continuous variables are conventional regression coefficients that indicate how much change is predicted for a unit change in the causal variable. The path coefficients to the categorical outcome are probit regression coefficients that indicate the strengths of the relationship between the predictive variable and the probability of group membership. To facilitate interpretation of the coefficients, the brain measures were rescaled. Normalized frontal lobe volume (absolute volume divided by total intracranial volume) was multiplied by a factor of 100, and normalized lesion volume was multiplied by a factor of 1000. These simple transformations rescaled the coefficients to a more readable format without changing any of the statistical results.
We also explored the role of cognitive state/compromise in two different modifications of the primary model. The mean MMSE was used as the marker of cognitive status. First, we evaluated the fit of a model that postulated that cognitive status was a result of high-intensity lesions and an intermediate or mediating variable in the diagnosis of depression. This model was suggested by a recent report that examined the relationship between depressive symptoms, structural brain changes, and cognition (Sato et al. 1999) . Second, we evaluated a model that instead posited that cognitive status was a result rather than a cause of depression. These alternative models are not nested, so formal testing of the superiority of one over the other was not possible. However, we compared the relative indices of goodness of fit, parsimony, and plausibility of both models. For models of interest, we report the goodness-of-fit 2 and degrees of freedom as reported by Mplus for the estimated models, path coefficients, and standard errors. The specifics of the models that were evaluated are presented in Results. For convenience, we refer to the path coefficients as ␤ , the standard errors as SE, and the ratio of these as z. As a rough guide to statistical significance of the paths, this ratio of the path coefficient to its standard error was referred to the normal curve; the resultant two-tailed probability is reported as p .
RESULTS
The initial model tested is as depicted in Figure 1 but also included direct paths from age to CVRF ( ␤ ϭ 0.076; SE ϭ 0.065; z ϭ 1.17; p ϭ .24) and to lesions ( ␤ ϭ 0.114; SE ϭ 0.076; z ϭ 1.51; p ϭ .13) (Figure 2, model A) . Neither of these paths was significant, so the model was reevaluated without them. Goodness-of-fit 2 for the primary model ( Figure 1 ) was 3.92 with df ϭ 7 ( p ϭ .79), indicating that the model was statistically plausible. The relevant statistical data are incorporated into Figure 1 . All of the path coefficients were large relative to their standard errors.
Subsequent analyses tested a variety of alternative specifications (Figure 2) . One of these included direct paths from age to MDD ( ␤ ϭ 0.02; SE ϭ 0.03; z ϭ 0.75; p ϭ .46) and direct paths from CVRF ( ␤ ϭ Ϫ 0.027; SE ϭ 0.046; z ϭ Ϫ 0.59; p ϭ .55) and nonvascular medical comorbidity ( ␤ ϭ 0.021; SE ϭ 0.104; z ϭ 0.204; p ϭ 0.84) to MDD (Figure 2, model B) . Another model included a path from lesions to atrophy ( ␤ ϭ 0.01; SE ϭ 0.04; z ϭ 0.31; p ϭ .76). Addition of these various nonsignificant paths did not alter the direction or magnitude of the coefficients in the final model to any appreciable degree, and the causal paths from both brain measures to MDD diagnosis remained large and significant. Similarly, the addition of paths from nonvascular medical comorbidity ( ␤ ϭ 0.007; SE ϭ 0.10; z ϭ 0.076; p ϭ .94) and CVRF ( ␤ ϭ 0.01; SE ϭ 0.05; z ϭ 0.18; p ϭ .86) to atrophy were not significant and did not alter the significance of any of the results as summarized in Figure 1 (Figure 2, model C) .
Additional analyses were performed to explore the role of cognitive status in the explanatory model. The mean MMSE was used as the index of the cognitive state. One model postulated that cognitive status was a mediating variable, resulting from lesions and causing MDD. Initial estimation of this model indicated a very poor fit ( 2 ϭ 32.86, df ϭ 9, p Ͻ .0001). Inspection of the modification indices indicated that this model did not adequately account for the covariance between MMSE and nonvascular comorbidity. When an additional direct path from noncardiovascular comorbidity to MMSE was added, the resulting model did fit well (goodness-of-fit 2 ϭ 6.75; df ϭ 8; p ϭ .56). The direct path from cognitive state to MDD was significant ( ␤ ϭ Ϫ 0.256, SE ϭ 0.056, z ϭ Ϫ 4.59, p Ͻ .001). Paths from both brain measures to MDD remained significant as well. This suggests that lesions have a causal role in MDD over and above any cognitive effects they may induce. We then evaluated an alternative model that posited that the cognitive status (MMSE) was a result rather than a cause of MDD. As detailed above, it was necessary to include the direct path from nonvascular comorbidity to MMSE to obtain an acceptable overall fit (goodness-of-fit 2 ϭ 4.51, df ϭ 8, p ϭ .80). This model ap- peared to be preferable. It had a slightly better goodnessof-fit index and required estimation of one less parameter. Thus, it was more parsimonious than the model that postulated that cognitive status was a cause of MDD without sacrificing goodness of fit. Paths from atrophy and lesions to MDD remained highly significant in all models that incorporated cognitive status.
DISCUSSION
In this study, we elaborate on our earlier observations and incorporate the relationships between several salient clinical and neurobiological measures into a holistic model of the pathophysiology of late-life MDD. Our data indicate that there are two distinct paths to late-life MDD. Nonvascular and vascular medical comorbidity contributing to high-intensity lesions that in turn lead to MDD represents one path. Smaller frontal lobes, as a marker of neuronal atrophy, represent another path to MDD. Both cerebrovascular and nonvascular medical burden exert no influence on frontal lobe volume, thereby suggesting that atrophy may reflect a neurobiological path that is distinct from the cumulative effects of medical insults to the central nervous system (CNS). In our model, age had a direct influence on frontal brain volume and an indirect influence on lesions mediated by nonvascular medical disorders. Those mediating paths accounted for the association between increasing age and the risk of MDD. Age per se had no direct impact on MDD in our study. Smaller brain volumes, estimated using in vivo MR imaging, have been identified in the prefrontal, mesial temporal, and subcortical areas in patients with MDD when compared with controls (Kumar et al. 2000) . In general, the prefrontal region has been more consistently implicated in the pathophysiology of psychiatric disorders. Postmortem neuropathological reports also demonstrate structural changes in the prefrontal regions in brain tissue obtained from patients who were diagnosed with MDD when compared with controls (Duman and Charney 1999; Rajkowska et al. 1999; Rajkowska 2000) . These changes include decreases in cortical thickness and neuronal size together with reductions in neuronal and glial density (Duman and Charney 1999; Rajkowska et al. 1999) . Although the etiology of these neuronal changes is unknown, genetic and other neurobiological explanations have been offered to explain these sets of observations (Duman and Charney 1999; Rajkowska et al. 1999; Sheline 2000) . Stress and clinical depression are often associated with hypercortisolemia, which has neurotoxic properties (Sapolsky and Pulsinelli 1985) . It has been suggested that stress-induced reductions in neurotrophins may also play a role in the structural changes observed in patients with MDD (Duman and Charney 1999) . A complex set of interrelated neurobiological events may constitute the path that leads from smaller frontal brain volume to late-life MDD (Gould et al.1998; Lopez et al. 1998) . In this study, we emphasize the principal medical/neuronal pathways that lead to MDD. However, at a cellular level, each principal pathway is likely to be composed of smaller paths and components, each with its distinctive biological characteristics (Gould et al. 1998; Lopez et al. 1998; Duman and Charney 1999) .
MDD is also characterized by an increase in MRI-determined high-intensity lesions in neocortical and subcortical areas. The apparent link of these lesions to vascular disease has led to speculation that the presence of these lesions suggests an underlying etiology that is predominantly vascular in origin (O'Brien et al. 1996; Krishnan et al. 1997; Hickie and Scott 1998) The neuropathological correlates of high-intensity lesions are diverse and include areas of white matter ischemia, edema, demyelination, and perivascular spaces in the neocortical and subcortical areas of the brain (Awad et al. 1986; Braffman et al. 1988; Drayer 1988; Spangler et al. 1994; Ylikoski et al. 1995) . Our data indicate that vascular and nonvascular comorbidity contribute to these lesions. It should be emphasized that vascular and nonvascular comorbidity together account for ‫%52ف‬ of the variance in lesion volumes in our sample, thereby suggesting that other unknown biological factors also contribute substantially to these lesions that are captured as high-intensity areas on MR images (Ylikoski et al. 1995) . Furthermore, whereas the cerebrovascular risk factors examined in our study primarily reflect macrovascular disease, it is likely that compromise to the microvasculature, secondary to disorders such as diabetes, also plays an important role (Lyness et al. 1998) . Impairments in brain oxygenation, secondary to chronic obstructive pulmonary disease (COPD), and a combination of disease processes/mechanisms may, under the rubric of "nonvascular medical comorbidity," collectively contribute to the pathophysiology of these lesions (Borson et al. 1998) . Their origins are therefore likely to be multifactorial, with vascular injury representing an important, though not exclusive, contributing factor.
A recent report from the Cardiovascular Health Study drew the conclusion that a decrease in cognitive status, as measured by a modified version of the MMSE, served as an intermediate step between neocortical lesions and mood symptoms (Sato et al. 1999) . In our study sample, the alternative model, which posited that cognitive impairments are a consequence or associated feature of MDD, was a somewhat better fit for our data. In any case, none of these competing models affected conclusions regarding the direct path between brain anatomical compromise and MDD. The direct effects of lesions on MDD cannot be accounted for by the presumed effects of lesions on cognition. Conversely, the effects on cognition could be explained as the results of MDD. Cognitive changes are frequently encountered clinically in elderly patients with a mood disorder (Emery and Oxman 1992; Alexopoulos et al. 1993) . The relationship between mood and cognition, especially in the elderly, is both complex and dynamic (Alexopoulas et al. 1993 (Alexopoulas et al. , 2000 . Longitudinal data incorporating the impact of treatment on both sets of measures are needed in order to make a more definitive statement (Alexopoulas et al. 1993 (Alexopoulas et al. , 2000 .
Prevalence estimates of MDD are lower in the elderly when compared with non-elderly adult samples (Blazer et al. 1987 ). Our findings clarify how age influences MDD. They suggest that the neuronal and medical consequences of increasing age contribute to both smaller regional brain volumes and greater high-intensity lesions, which in turn lead to MDD. Therefore, whereas age per se has no deleterious impact on mood, the overall biological/medical correlates of aging compromise brain structure, thereby predisposing individuals to clinically significant mood disturbances.
A few limitations of our current analysis and report need to be acknowledged. First, the preliminary relationships observed in our earlier analysis provided the basis of the more definitive path analysis and hypotheses testing described in this study. Second, path analysis, by its very nature, is often a hybrid between hypothesis testing and hypothesis confirmation (Mintz and Dixon 1997) . Therefore, although we started our analysis with a specific conceptual model of pathways to MDD, subtle variations from this initial model were also critically examined, as described. In general, such models and paths are better assessed on the biological plausibility of their findings rather than mere statistical possibility. Direction of causality may be inferred but not definitively determined with this design. Caution is needed in interpreting cross-sectional data in diseases with a longitudinal course (Kraemer et al. 2000) . The models examined in our study and the principal pathways elucidated are consistent with established neurobiological and clinical correlates of late-life mood disorders and provide early insights into the medical and neurobiological basis of mood disorders. Finally, we would like to comment on the power of our analysis. A sample size of n ϭ 100 is usually recommended for the kind of analysis performed in our study (Bollen 1989 ). Although our sample size (n ϭ 81) is a bit smaller than traditionally recommended, the goodness-of-fit 2 is small in our analyses and the parameters are many times larger than the standard error. These caveats indicate that our sample size was adequate and the power sufficient to detect our findings.
The etiology of mood disorders in the elderly is multifactorial, and biological injury as well as psychosocial stressors may contribute to the clinical manifestations commonly observed in practice. Our data indicating that there are relatively distinct pathways that lead from underlying medical/biological substrates to MDD may have important implications for the primary and possibly secondary prevention of behavioral disorders in the elderly. Early diagnosis and aggressive management of medical illness could play an important role in reducing psychiatric morbidity in this vulnerable segment of the population. Judicious medical management could be complementary to treatment with antidepressants that remains the primary focus of pharmacological intervention in patients with significant mood disorders. 
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The statistical methodology of path analysis remains relatively unfamiliar in the neurosciences. It is an extension of regression analysis that attempts to separate causal influences among a set of variables into direct and indirect (or mediating) pathways. Path analysis makes it possible to model more complex systems than is possible with usual multiple regression models that include only a single dependent variable. Path models typically include intervening variables, often at multiple causal levels, and may omit paths presumed to be irrelevant. Using the methods of structural equation modeling (SEM), overall evaluation of an entire postulated system of causal relations is possible.
Multiple logistic regression analysis, as employed in a previous report of this study (Kumar et al. 2000) , evaluates the significance of direct associations from a set of predictor variables to the occurrence of depression. Path analy-sis, as employed in this report, makes it possible to simultaneously evaluate the statistical plausibility of the entire set of posited causal relationships. As depicted in the main Figure 1 , this is a multilevel model that includes both direct and indirect causal paths. The goodness-of-fit 2 tests the deviation of the data from the model. When significant, it indicates that the data do not fit the posited causal model. Thus, a nonsignificant goodness-of-fit 2 is desirable, in that it indicates that the posited causal model is statistically plausible in light of the observed data. Of course, the fact that a model is plausible does not guarantee that it is correct. It is not at all uncommon for several alternative models to "fit" the data (as occurred in this case).
The Mplus software makes it possible to simultaneously evaluate multistage models including both continuous and dichotomous dependent variables. In the former case, the path (regression) coefficients are conventional linear regression coefficients, indicating the expected change in the dependent variable for a unit change in the independent variable. In the case of dichotomous dependent variables (e.g., depression in the current analyses), the coefficients are probit coefficients. As such, they represent the change in the probability of "caseness" associated with a unit change in the independent variable. The model underlying the probit portion of the analysis is that the likelihood of observing the outcome (depression in this case) is based on one's position on a hypothetical, unobserved normal curve. The probit equation estimates a linear combination of predictors to predict the z-score representing one's position on that curve and thus the probability of being a case.
